Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum.

Q4 Medicine

Clinical Pulmonary Medicine Pub Date : 2022-03-09 eCollection Date: 2022-03-01 DOI:10.1259/bjrcr.20210063

Besma Musaddaq, Adam Brown, Sam Dluzewski, Teresa Marafioti, Anmol Malhotra

引用次数: 0

Abstract

A number of COVID-19 vaccines have been approved worldwide to help tackle the pandemic. As with many vaccines, this causes a reactive axillary lymphadenopathy which can mimic potentially metastatic disease in a breast screening patient. It is therefore important to be aware of this side-effect of the vaccination when evaluating the axilla in a breast screening patient. We present a case of biopsy-proven unilateral reactive axillary lymphadenopathy in a high risk BRCA carrier following administration of the Astra Zeneca vaccine.

查看原文本刊更多论文

一名接种 COVID-19 疫苗后接受乳腺筛查的高危患者出现腋窝淋巴结病：诊断难题。

全球已批准了多种 COVID-19 疫苗，以帮助应对这一流行病。与许多疫苗一样，这种疫苗会引起反应性腋窝淋巴结病，这可能是乳腺筛查患者潜在转移性疾病的假象。因此，在对乳腺筛查患者的腋窝进行评估时，必须注意疫苗接种的这种副作用。我们介绍了一例经活检证实的单侧反应性腋窝淋巴结病例，患者是一名高风险 BRCA 携带者，在接种阿斯利康疫苗后出现该症状。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Pulmonary Medicine Medicine-Critical Care and Intensive Care Medicine

自引率

0.00%

发文量

期刊介绍： Clinical Pulmonary Medicine provides a forum for the discussion of important new knowledge in the field of pulmonary medicine that is of interest and relevance to the practitioner. This goal is achieved through mini-reviews on focused sub-specialty topics in areas covered within the journal. These areas include: Obstructive Airways Disease; Respiratory Infections; Interstitial, Inflammatory, and Occupational Diseases; Clinical Practice Management; Critical Care/Respiratory Care; Colleagues in Respiratory Medicine; and Topics in Respiratory Medicine.